The largest CDMO in Korea
Established in 2002, PENMIX is a pharmaceutical company specializing in CDMO, with services specifically for penicillin and injections.
continues to develop new medicines through relentless R&D activities, while manufacturing and supplying end-user pharmaceutical products to dozens of countries including Japan.
offers the following CDMO services.
The PENMIX Development Division maximizes the business efficiency by conducting research planning, product development, research activities, and licensing all together. Currently, we are an organization specializing in injections and penicillin in accordance with global standards, and our aim is to grow into a professional research and development organization for all types of formulations in the future.